Medical Xpress August 22, 2024
Injectable weight-loss medications called semaglutides are helping people with obesity by reducing appetite. But could these drugs also be the next breakthrough in keeping your heart healthy?
The Food and Drug Administration recently approved Wegovy, a brand name of semaglutide, as a secondary prevention medication to reduce risk of serious heart problems.
Could your cardiologist soon be prescribing the weight-loss drug Wegovy to improve your heart health?
“It wasn’t the weight loss necessarily that drove that benefit. It was something that seemed very specific to this semaglutide itself,” says Dr. Meera Shah, a Mayo Clinic endocrinologist.
A study published in November 2023 showed that, in adult patients with obesity who already have cardiovascular disease, Wegovy reduced the risk of heart...
Today's Sponsors
Today's Sponsor